Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Biotronik AG

FDA 510(k) & PMA Approved Devices — 4 products

Total Devices4
Categories4
Latest FDA decision2026-08-07
TypeNumberDevice NameCodeDateActions
PMA P170030 Coronary drug-eluting stentNIQ2026-08-07 View
PMA P140030 STENT, ILIACNIO2026-06-22 View
PMA P160025 STENT, SUPERFICIAL FEMORAL ARTERYNIP2026-06-22 View
PMA P160003 STENT, CORONARYMAF2026-06-05 View

Related Clinical Trials

NCT05540223Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold SystemACTIVE_NOT_RECRUITINGNCT06540079BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP SCOMPLETEDNCT07091682Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo LesionsRECRUITINGNCT07118358BIOTRONIK Investigation of the LivIQ Leadless Pacemaker SystemRECRUITINGNCT01516723Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary OcclusionsCOMPLETEDNCT03884257A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon.ACTIVE_NOT_RECRUITINGNCT04869527Full Early Atrial Diagnostics in Single Chamber ICD Patients Using the DX Lead and Home Monitoring in Brazil.COMPLETEDNCT06710210Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery DiseaseRECRUITINGNCT07360158BIO|MASTER.CorSky Family Post-market Study for the CorSky Family of ICDsRECRUITINGNCT07393009BIO|STREAM.CSP StudyRECRUITING
↑